Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
27,523
-201
-0.7% -$14K 0.01% 962
2026
Q1
$1.67M Buy
27,724
+5,806
+26% +$393K 0.01% 998
2025
Q4
$1.38M Buy
21,918
+1,535
+8% +$99.6K 0.01% 1051
2025
Q3
$1.43M Buy
20,383
+2,857
+16% +$201K 0.01% 917
2025
Q2
$1.13M Buy
17,526
+10,426
+147% +$657K 0.01% 929
2025
Q1
$487K Buy
7,100
+161
+2% +$12K 0.01% 1148
2024
Q4
$501K Buy
6,939
+931
+15% +$74.5K 0.01% 1076
2024
Q3
$506K Buy
6,008
+2,474
+70% +$188K 0.01% 865
2024
Q2
$236K Buy
+3,534
New +$249K 0.01% 795

Other funds holding MAS

&Partners's MAS Position: Q2 2026 in Review

&Partners reduced its Masco (MAS) stake by 0.73% in Q2 2026, selling an estimated $14K and leaving 27,523 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #962.

&Partners first reported a position in MAS in Q2 2024 and has held it in 9 quarters since. 920 funds tracked by Wall St. Rank hold MAS as of Q2 2026.

  • &Partners held 27,523 shares of Masco worth $2.24M as of Q2 2026.
  • &Partners sold 201 Masco shares in Q2 2026, an estimated $14K.
  • Masco made up 0.01% of &Partners's portfolio in Q2 2026, its #962 holding.
  • &Partners first reported a position in Masco in Q2 2024 and has held it in 9 quarters since.
  • 920 funds tracked by Wall St. Rank held Masco as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.